NRx Pharmaceuticals Inc. (NRXP) Bullish After Hours on its Upcoming COVID-19 Vaccine Presentation
On January 07, NRx Pharmaceuticals Inc. (NRXP) announced its upcoming company updates presentation at the H.C. Wainwright BioConnect conference. The company will be discussing new details of its Covid-19 vaccine trial during the presentation. Consequently, the stock became bullish in the after-hours on the news. During regular trading, NRXP stock lost 7.34% at its closing […]